Income Taxes - Summary of Significant Components of Net Deferred Income Tax Assets and Liabilities (Details) - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Deferred income tax assets and liabilities | ||
Accrued compensation and other | $ 11,000 | $ 11,000 |
Less: valuation allowance | (11,000) | (11,000) |
Current deferred income tax assets | 0 | 0 |
Net operating loss | 13,642,000 | 13,013,000 |
Research and development credit | 18,000 | 18,000 |
Research and experimental costs | 595,000 | |
Warrants issued for services | 45,000 | 45,000 |
Depreciation and amortization | 135,000 | 126,000 |
Exercise of options and warrants | (36,000) | (33,000) |
Stock based compensation | 1,149,000 | 1,028,000 |
Intangibles and other | (633,000) | (606,000) |
Less: valuation allowance | (14,915,000) | (13,591,000) |
Net non-current deferred tax assets | $ 0 | $ 0 |
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized, current. No definition available.
|
X | ||||||||||
- Definition Deferred liabilities valuation allowance non-current. No definition available.
|
X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting, current. No definition available.
|
X | ||||||||||
- Definition Deferred tax assets non-current. No definition available.
|
X | ||||||||||
- Definition Represents the information pertaining to deferred tax liabilities options and warrants. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from derivative instruments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|